{"id":"https://openalex.org/W2007661473","doi":"https://doi.org/10.1158/0008-5472.sabcs-4109","title":"Adjuvant chemotherapy for breast cancer \u2013 prognostic impact of relative dose-intensity.","display_name":"Adjuvant chemotherapy for breast cancer \u2013 prognostic impact of relative dose-intensity.","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2007661473","doi":"https://doi.org/10.1158/0008-5472.sabcs-4109","mag":"2007661473"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs-4109","doi":"https://doi.org/10.1158/0008-5472.sabcs-4109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs-4109","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114017727","display_name":"Steffen Kahlert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S Kahlert","raw_affiliation_strings":["1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074818367","display_name":"Jeffrey Victor Rosenfeld","orcid":"https://orcid.org/0000-0003-3827-9898","observed_orcids":["https://orcid.org/0000-0003-3827-9898"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J Rosenfeld","raw_affiliation_strings":["1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111863128","display_name":"K. Mair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Mair","raw_affiliation_strings":["1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y Sorokina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Sorokina","raw_affiliation_strings":["2 Dept OB/GYN, Kreisklinik, Ebersberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Dept OB/GYN, Kreisklinik, Ebersberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109285275","display_name":"J. Engel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J Engel","raw_affiliation_strings":["3 Tumorregistry Munich, Inst. for Biometry and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3 Tumorregistry Munich, Inst. for Biometry and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110331350","display_name":"K Friese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K Friese","raw_affiliation_strings":["1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Dept. OB/GYN, Klinikum Grosshadern, Ludwig-Maximilians-Universitaet, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"2_Supplement","first_page":"4109","last_page":"4109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/relative-dose-intensity","display_name":"relative dose intensity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6679999828338623},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.7360000014305115},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cmf","display_name":"CMF","score":0.7570000290870667},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.949999988079071},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.800000011920929},{"id":"https://openalex.org/keywords/metastasis-free-survival","display_name":"metastasis-free survival","score":0.9580000042915344},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.597000002861023},{"id":"https://openalex.org/keywords/dose-delay","display_name":"dose delay","score":0.48100000619888306},{"id":"https://openalex.org/keywords/treatment-completion","display_name":"treatment completion","score":0.3330000042915344},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.3540000021457672},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.30300000309944153},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6460000276565552},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8609288334846497},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8568223714828491},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7514252662658691},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6546616554260254},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6524569988250732},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6372682452201843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5065397024154663},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43200254440307617},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41628026962280273},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3694983720779419}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs-4109","doi":"https://doi.org/10.1158/0008-5472.sabcs-4109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs-4109","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2082467759","https://openalex.org/W2187372657","https://openalex.org/W2248847637","https://openalex.org/W3022715428","https://openalex.org/W2150887515","https://openalex.org/W2471305186","https://openalex.org/W2612724718","https://openalex.org/W2136802843","https://openalex.org/W1842248410","https://openalex.org/W4400797939"],"abstract_inverted_index":{"Abstract":[0,1],"#4109":[2],"Introduction:":[3],"Maintenance":[4],"of":[5,17,36,44,69,92,204,299,330,335],"adequate":[6],"dose":[7,115,140,211,225,239,406],"intensity":[8],"(DI)":[9],"is":[10,33,179,392],"an":[11],"important":[12],"aim":[13],"in":[14,55,207,213,365,397,401],"the":[15,31,37,42,63,128,134,173,363],"use":[16],"adjuvant":[18,169],"chemotherapy":[19,141,205],"for":[20,51,224,293,308,315,349],"early":[21],"breast":[22],"cancer.":[23],"Some":[24],"studies":[25],"report":[26],"a":[27,67,113,296,338],"decreased":[28,45],"survival,":[29],"if":[30],"DI":[32,46,256,298,332,342,356,364,391],"below":[34],"80%":[35,286,311],"planned":[38],"dose.":[39],"We":[40],"evaluated":[41],"rate":[43],"and":[47,60,85,127,159,186,195,230,248,262,265,282,321,351,377],"its":[48],"prognostic":[49],"impact":[50],"patients":[52],"(pts.)":[53],"treated":[54,111],"our":[56,122,388],"institution":[57,156],"between":[58],"1990":[59],"2004.":[61],"During":[62],"long":[64],"observation":[65],"period":[66],"variety":[68],"regimens":[70,79,147],"were":[71,101,110,119,136,220,241,257],"used:":[72],"CMF,":[73,192],"normal":[74],"dosed":[75,87],"anthracycline":[76],"(norA)":[77,247,261],"based":[78],"(Epirubicin":[80],"less":[81,300],"than":[82,94,149,227,301,314],"35":[83],"mg/sqm*week)":[84],"higher":[86,222],"anthracyclines":[88],"(hiA;":[89],"Epirubicin":[90],"doses":[91],"more":[93,306],"45":[95],"mg/sqm*week).":[96],"Methods:":[97],"All":[98],"patient":[99,372],"files":[100],"reviewed":[102],"to":[103,355,384],"calculate":[104],"relative":[105],"DI;":[106],"cycles":[107],"not":[108,344,400],"applied":[109],"as":[112,346],"100%":[114],"reduction.":[116],"Follow":[117],"up-data":[118],"taken":[120],"from":[121,133,358],"institutional":[123],"prospective":[124,360],"data":[125],"base":[126],"regional":[129],"tumor":[130],"registry.":[131],"Excluded":[132],"analysis":[135,340],"pts.":[137,154,160,167,190,199,215,294],"with":[138,142,182,228,295,394],"high":[139],"stem":[143],"cell":[144],"support,":[145],"rare":[146],"(less":[148],"10":[150],"cases":[151],"/":[152],"regimen),":[153],"switching":[155],"during":[157,162],"therapy":[158],"progressing":[161],"chemotherapy.":[163],"Results:":[164],"From":[165],"966":[166],"receiving":[168,218],"chemotherapy,":[170],"887":[171],"matched":[172],"inclusion":[174],"criteria.":[175],"Mean":[176,238],"follow":[177],"up":[178],"70":[180],"months":[181],"260":[183],"distant":[184],"progressions":[185],"234":[187],"deaths.":[188],"193":[189],"received":[191,200],"442":[193],"norA":[194,229,309],"252":[196],"hiA,":[197],"302":[198],"taxanes.":[201],"Preterm":[202],"termination":[203,379],"occurred":[206],"77":[208],"pts":[209],"(8.7%),":[210],"reductions":[212,226],"36":[214],"(4.1%).":[216],"Pts.":[217],"hiA":[219,322],"at":[221],"risk":[223],"CMF":[231,316],"(7.5%":[232],"vs.":[233,235,279,287,312,319,325],"2.9%":[234],"2.1%,":[236],"p=0.015).":[237],"delays":[240,376],"12.7":[242],"days":[243,246],"(CMF),":[244,259],"6.4":[245],"5.7":[249],"(hiA)":[250,264],"(p<0.01,":[251],"Kruskal-Wallis-test).":[252,269],"The":[253,327],"mean":[254],"rel.":[255,297],"90%":[258],"93%":[260],"92%":[263],"significantly":[266,291],"different":[267],"(p=0.01,":[268],"In":[270,337,387],"univariate":[271],"analysis,":[272],"5":[273],"year-metastasis":[274],"free":[275],"survival":[276,284],"(MFS,":[277],"74%":[278,318],"55%,":[280],"p=0.002)":[281],"overall":[283],"(OAS,":[285],"65%,":[288],"p=0.009)":[289],"are":[290,380],"lower":[292],"80%.":[302],"This":[303],"effect":[304,329],"seems":[305,368],"pronounced":[307],"(OAS":[310,317,323],"45%),":[313],"74%)":[320],"85%":[324],"77%).":[326],"adverse":[328,395],"low":[331,341,390],"was":[333,343],"independent":[334,347],"taxan-use.":[336],"cox-regression":[339],"identified":[345],"predictor":[348],"MFS":[350],"OAS.":[352],"Conclusions:":[353],"Compared":[354],"reported":[357],"most":[359],"randomised":[361],"trials":[362],"this":[366],"study":[367,389],"lower,":[369],"potentially":[370],"reflecting":[371],"selection.":[373],"Dose":[374],"reductions,":[375],"preterm":[378],"common":[381],"findings,":[382],"leading":[383],"impaired":[385],"DI.":[386],"associated":[393],"prognosis":[396],"univariate,":[398],"but":[399],"multivariate":[402],"analysis.":[403],"Nevertheless,":[404],"unnecessary":[405],"modifications":[407],"should":[408],"be":[409],"avoided.":[410],"Citation":[411],"Information:":[412],"Cancer":[413],"Res":[414],"2009;69(2":[415],"Suppl):Abstract":[416],"nr":[417],"4109.":[418]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}